Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2021 Filed Dec 3, 2021 22:25 UTC | SaleCommon Stock | 250,000 | $1.87 | $467,500.00 |
DisclosureSEC source: 0001493152-21-030491 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,957,832 Read SEC document |
|
| November 29, 2021 Filed Dec 2, 2021 01:01 UTC | SaleCommon Stock | 100,000 | $1.69 | $168,810.00 |
DisclosureSEC source: 0001493152-21-030239 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,207,832 Read SEC document |
|
| November 24, 2021 Filed Nov 30, 2021 00:33 UTC | SaleCommon Stock | 100,000 | $1.64 | $163,790.00 |
DisclosureSEC source: 0001493152-21-030042 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,307,832 Read SEC document |
|
| November 09, 2021 Filed Nov 12, 2021 11:12 UTC | SaleCommon Stock | 300,000 | $2.02 | $604,560.00 |
DisclosureSEC source: 0001493152-21-027942 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,407,832 Read SEC document |
|
| October 21, 2021 Filed Oct 25, 2021 23:01 UTC | SaleCommon Stock | 248,416 | $2.26 | $561,420.16 |
DisclosureSEC source: 0001493152-21-026278 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,707,832 Read SEC document |
|
| October 20, 2021 Filed Oct 23, 2021 00:11 UTC | SaleCommon Stock | 24,209 | $2.25 | $54,470.25 |
DisclosureSEC source: 0001493152-21-026120 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,956,248 Read SEC document |
|
| October 19, 2021 Filed Oct 22, 2021 00:07 UTC | SaleCommon Stock | 16,326 | $2.25 | $36,733.50 |
DisclosureSEC source: 0001493152-21-026020 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,980,457 Read SEC document |
|
| October 14, 2021 Filed Oct 18, 2021 23:22 UTC | SaleCommon Stock | 100,726 | $2.18 | $219,582.68 |
DisclosureSEC source: 0001493152-21-025735 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,996,783 Read SEC document |
|
| October 13, 2021 Filed Oct 15, 2021 23:47 UTC | SaleCommon Stock | 58,739 | $2.25 | $132,162.75 |
DisclosureSEC source: 0001493152-21-025627 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,097,509 Read SEC document |
|
| October 12, 2021 Filed Oct 14, 2021 23:17 UTC | SaleCommon Stock | 100,000 | $2.13 | $213,000.00 |
DisclosureSEC source: 0001493152-21-025477 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,156,248 Read SEC document |
|
| October 08, 2021 Filed Oct 13, 2021 00:43 UTC | SaleCommon Stock | 200,000 | $2.30 | $460,000.00 |
DisclosureSEC source: 0001493152-21-025244 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256,248 Read SEC document |
|
| September 28, 2021 Filed Oct 1, 2021 01:18 UTC | SaleCommon Stock | 200,000 | $2.48 | $496,000.00 |
DisclosureSEC source: 0001493152-21-024258 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,456,248 Read SEC document |
|
| September 28, 2021 Filed Sep 30, 2021 13:51 UTC |
Parmakellis TomDirector
|
PurchaseCommon stock | 1,000 | $2.40 | $2,400.00 |
DisclosureSEC source: 0001493152-21-024159 · ownership.xml · nonDerivative · entry 1 Parmakellis Tom · CIK 0001830109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| September 24, 2021 Filed Sep 29, 2021 01:39 UTC | SaleCommon Stock | 200,000 | $2.66 | $532,000.00 |
DisclosureSEC source: 0001493152-21-024060 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,656,248 Read SEC document |
|
| September 23, 2021 Filed Sep 28, 2021 01:42 UTC | SaleCommon Stock | 100,000 | $2.77 | $277,000.00 |
DisclosureSEC source: 0001493152-21-023918 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,856,248 Read SEC document |
|
| September 22, 2021 Filed Sep 24, 2021 22:22 UTC | SaleCommon Stock | 100,000 | $2.80 | $280,000.00 |
DisclosureSEC source: 0001493152-21-023639 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,956,248 Read SEC document |
|
| September 21, 2021 Filed Sep 24, 2021 00:45 UTC | SaleCommon Stock | 100,000 | $2.83 | $283,000.00 |
DisclosureSEC source: 0001493152-21-023522 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,056,248 Read SEC document |
|
| September 20, 2021 Filed Sep 23, 2021 01:37 UTC | SaleCommon Stock | 100,000 | $2.90 | $290,000.00 |
DisclosureSEC source: 0001493152-21-023418 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,156,248 Read SEC document |
|
| September 17, 2021 Filed Sep 22, 2021 10:20 UTC | SaleCommon Stock | 45,152 | $3.29 | $148,550.08 |
DisclosureSEC source: 0001493152-21-023315 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,256,248 Read SEC document |
|
| June 21, 2021 Filed Jun 28, 2021 10:12 UTC |
Parmakellis TomDirector
|
PurchaseCommon stock | 1,000 | $4.44 | $4,440.00 |
DisclosureSEC source: 0001493152-21-015332 · ownership.xml · nonDerivative · entry 1 Parmakellis Tom · CIK 0001830109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| May 19, 2021 Filed May 22, 2021 01:51 UTC |
Sakiris Spiro KevinChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $3.07 | $30,660.00 |
DisclosureSEC source: 0001493152-21-012575 · ownership.xml · nonDerivative · entry 1 Sakiris Spiro Kevin · CIK 0001830957 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,258 Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 00:24 UTC |
Gavrilenko VictoriaDirector
|
PurchaseGBS Common Stock | 36.63 | $8.09 | $296.34 |
DisclosureSEC source: 0001493152-21-005316 · ownership.xml · nonDerivative · entry 1 Gavrilenko Victoria · CIK 0001830108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36.63 Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 12:22 UTC |
TOWERS CHRISTOPHERDirector
|
PurchaseCommon Stock | 800 | $6.84 | $5,472.00 |
DisclosureSEC source: 0001493152-21-004780 · ownership.xml · nonDerivative · entry 1 TOWERS CHRISTOPHER · CIK 0001775875 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800 Read SEC document |
| January 18, 2021 Filed Jan 21, 2021 20:32 UTC | OtherSeries B Warrants · Derivative | 117,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-001520 · ownership.xml · derivative · entry 2 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 117,647 shares Expires not disclosed F1 · derivative.exercise_price: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. F1 · price: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. F1 · derivative.exercise_date: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. F1 · derivative.expiration_date: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. Read SEC document |
|
| January 18, 2021 Filed Jan 21, 2021 20:32 UTC | OtherCommon Stock | 117,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-001520 · ownership.xml · nonDerivative · entry 1 Life Science Biosensor Diagnostics Pty Ltd · CIK 0001831656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,786,694 F1 · security: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. F1 · price: Represents exercise of the Series B Common Stock Purchase Warrant to purchase 117,647 shares of the Company's common stock; on a cashless basis under the terms of the warrant. The warrant term was five years from the issuance date. Read SEC document |
|
| January 04, 2021 Filed Feb 17, 2021 00:04 UTC |
Sakiris Spiro KevinChief Financial Officer
|
OtherSeries B Warrants · Derivative | 1,479 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-004072 · ownership.xml · derivative · entry 2 Sakiris Spiro Kevin · CIK 0001830957 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,479 shares Expires not disclosed F1 · derivative.exercise_price: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. F1 · price: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. F1 · derivative.exercise_date: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. F1 · derivative.expiration_date: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. Read SEC document |
| January 04, 2021 Filed Feb 17, 2021 00:04 UTC |
Sakiris Spiro KevinChief Financial Officer
|
OtherCommon Stock | 1,479 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-21-004072 · ownership.xml · nonDerivative · entry 1 Sakiris Spiro Kevin · CIK 0001830957 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,258 F1 · security: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. F1 · price: Represents exercise of the Series B Common Stock Purchase Warrant (the "Warrant") to purchase 1,479 shares of the Company's common stock. The Reporting Person paid the exercise price of $17.00 per share on a cashless basis. The Warrant was exercisable until the fifth anniversary of the issuance date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.